ЗМІСТ

ORIGINAL CONTRIBUTIONS

Bilyk O.O., Pande N.T., Buchynska L.G.
Analysis of P53, P16INK4A, PRB and cyclin D1 expression and human papillomavirus in primary ovarian serous carcinoma

Krzystek-Korpacka M., Diakowska D., Gamian A., Matusiewicz M.
Increase in serum platelet-derived growth factor (PDGF)-BB reflects lymph node involvement in esophageal cancer patients independently from platelet count

Kiyamova R., Shyian M., Lyzogubov V.V., Usenko V.S., Gout T., Filonenko V.
Immunohistochemical analysis of NaPi2b protein (MX35 antigen) expression and subcellular localization in human normal and cancer tissues

Levkovich N.N., Gorovenko N.G., Myasoedov D.V.
Association of polymorphic G1934A variant (allele *4) of CYP2D6 gene with increased risk of breast cancer development in Ukrainian women

Labeikyte D., Borutinskaite V., Legzdins N., Sjakste N.
Tightly-bound to DNA proteins in rat experimental hepatomas and normal liver cells

Amikishieva A.V., Ilnitskaya S.I., Nikolin V.P., Popova N.A.
Effect of vasopressin V1b receptor antagonist, SSR149415, on anxiety-like behavior and lewis lung carcinoma metastasis in mice

Zhuravel E., Shestakova T., Efanova O., Yusefovich Yu., Kytvin D., Soldatkina M., Pogrebnoy P.
Human beta-defensin-2 controlS cell cycle in malignant epithelial cells: in vitro study

Solopan S., Belous A., Yelenich A., Bubnovskaya L., Kovelskaya A., Podoltsev A., Kondratenko I., Osinsky S.
Nanohyperthermia of malignant tumors.i. lanthanum-strontium manganite magnetic fluid as potential inducer of tumor hyperthermia

Shman T.V., Fedasenka U.U., Savitski V.P., Kustanovich A.M., Aleinikova O.V.
Drug resistance associated properties of blasts subpopulations with different CD34 expression in childhood acute lymphoblastic leukemia (ALL)

SHORT COMMUNICATIONS

Samoylenko O., Zaletok S., Orlovskiy O., Gogol S.
Additive antitumor effect of plant polyphenols and synthetic inhibitors of polyamines biosynthesis

Kudryavets Yu.I., Bezdenezhnykh N.O., Lykhova O.O., Semesiuk N.I., Vorontsova A.L.
The role of interferon as a modifier of epithelial-mesenchymal transition in tumor cells

Prylutska S.V., Burlaka A.P., Prylutskyy Yu.I., Ritter U., Scharff P.
Pristine C60 fullereneS inhibit the rate of tumor growth and metastasis

The first Ukrainian-Swedish Workshop “New approaches to diagnostics and treatment of cancer”

Jia M., Souchelnytskyi S.
Comments on the cross-talk of TGFβ and EGF in cancer

Souchelnytskyi S.
Current status and challenges of personalized treatment of cancer: view inspired by the workshop

Attarha S., Mints M., Andersson S., Souchelnytskyi S.
Endometrial cancer and application of proteomics

Demash D.V., Bazas V.M., Lukianova N.Yu, Rozumiy D.O., Chekhun V.F.
Molecular profile of gastric cancer as a basis of individualized treatment and prognosis of disease outcome

Timovska Yu., Pivnyuk V., Todor I., Anikusko N., Chekhun V.
The spectrum of blood serum lipids in patients with breast cancer without metabolic syndrome

Mints M., Souchelnytskyi S.
Proteomic Strategy for Detection of Circulating Tumor Cell Surface Antigens